Eventide Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-443,333	Closed	-$4.52M	–	247
2025 Q1	$4.52M	Hold	443,333	–	–	0.09%	147
2024 Q4	$6.18M	Sell	443,333 -183,334	-29%	-$2.56M	0.11%	148
2024 Q3	$12.2M	Buy	626,667 +124,727	+25%	+$2.43M	0.21%	110
2024 Q2	$9.34M	Buy	+501,940	New	+$9.34M	0.16%	125